Measuring multimorbidity in research: Delphi consensus study.
Measuring multimorbidity in research: Delphi consensus study.
复制标题
衡量研究中的多种多发病：Delphi共识研究。
DOI：
10.1136/bmjmed-2022-000247
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Guthrie, Bruce
中科院分区：
文献类型：
--
作者：
Ho, Iris S. S.;Azcoaga-Lorenzo, Amaya;Akbari, Ashley;Davies, Jim;Khunti, Kamlesh;Kadam, Umesh T.;Lyons, Ronan A.;McCowan, Colin;Mercer, Stewart W.;Nirantharakumar, Krishnarajah;Staniszewska, Sophie;Guthrie, Bruce
就研究中的多重死亡的定义和测量达成国际共识。德尔菲共识研究。国际共识;在2020年11月30日至2021年5月18日期间从参与者那里收集了三轮在线数据。对多元就业感兴趣的专业人士和长期条件的人被招募到专业和公共小组。150名专业人士和25名公众参与者完成了第一轮调查。第2/3轮的回应率分别为83%/92%的专业人士和88%/93%的公众小组。在两个小组中，共识是多死亡应被定义为两个或两个以上的长期条件。人们认为，复杂的多重死亡是一个有用的概念，但专家组未能就如何界定它达成一致意见，两个专家组一致认为，如果有以下一种或多种情况，就应将其纳入多重死亡措施：目前正在活动;其影响是永久性的;需要目前的治疗、护理或疗法;需要监测;或需要持续护理的复发-缓解状况。达成的协商一致意见是，24项条件必须列入多重赔偿措施，35项条件通常列入，除非有充分的理由不存在。简单的计数是首选的估计患病率和检查集群或轨迹，加权的措施是首选的风险调整和结果预测。以前的多变量研究是有限的不一致的定义和方法来衡量多变量。这项德尔菲研究确定了专业和公众小组共识指南，以促进定义和测量的一致性，并提高研究的可比性和再现性。
To develop international consensus on the definition and measurement of multimorbidity in research. Delphi consensus study. International consensus; data collected in three online rounds from participants between 30 November 2020 and 18 May 2021. Professionals interested in multimorbidity and people with long term conditions were recruited to professional and public panels. 150 professional and 25 public participants completed the first survey round. Response rates for rounds 2/3 were 83%/92% for professionals and 88%/93% in the public panel, respectively. Across both panels, the consensus was that multimorbidity should be defined as two or more long term conditions. Complex multimorbidity was perceived to be a useful concept, but the panels were unable to agree on how to define it. Both panels agreed that conditions should be included in a multimorbidity measure if they were one or more of the following: currently active; permanent in their effects; requiring current treatment, care, or therapy; requiring surveillance; or relapsing-remitting conditions requiring ongoing care. Consensus was reached for 24 conditions to always include in multimorbidity measures, and 35 conditions to usually include unless a good reason not to existed. Simple counts were preferred for estimating prevalence and examining clustering or trajectories, and weighted measures were preferred for risk adjustment and outcome prediction. Previous multimorbidity research is limited by inconsistent definitions and approaches to measuring multimorbidity. This Delphi study identifies professional and public panel consensus guidance to facilitate consistency of definition and measurement, and to improve study comparability and reproducibility.
登录
查看更多内容
影响因子：
--
作者：
Griffith LE;Gruneir A;Fisher KA;Nicholson K;Panjwani D;Patterson C;Markle-Reid M;Ploeg J;Bierman AS;Hogan DB;Upshur R
通讯作者：
Upshur R
影响因子：
3.8
作者：
Hasson, F;Keeney, S;McKenna, H
通讯作者：
McKenna, H
影响因子：
3
作者：
Drye, Elizabeth E.;Altaf, Faseeha K.;Lin, Zhenqiu
通讯作者：
Lin, Zhenqiu
影响因子：
2.2
作者：
N'Goran, Alexandra A.;Blaser, Jeremie;Herzig, Lilli
通讯作者：
Herzig, Lilli
影响因子：
4.5
作者：
Sakib, Mohammad Nazmus;Shooshtari, Shahin;Menec, Verena
通讯作者：
Menec, Verena